The Business Research Company’s global market reports are now updated with the latest market sizing information for the year 2023 and forecasted to 2032

The Business Research Company’s vascular endothelial growth factor (VEGF) inhibitor market report forecasts the vascular endothelial growth factor (VEGF) inhibitor market size to grow to $12.11 Billion by 2027, with a CAGR (compound annual growth rate) of more than 7%.

Learn More On The Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report 2023 – https://www.thebusinessresearchcompany.com/report/vascular-endothelial-growth-factor-inhibitors-global-market-report

Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Size Forecast

The global vascular endothelial growth factor (VEGF) inhibitor market is expected to grow from $8.27 billion in 2022 to $8.96 billion in 2023 at a compound annual growth rate (CAGR) of 8.3%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The vascular endothelial growth factor (VEGF) inhibitor market is expected to grow from $12.11 billion in 2027 at a CAGR of 7.8%.

North America held the largest vascular endothelial growth factor (VEGF) inhibitor market share, and North Americ was the fastest-growing region in 2022.

Key Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Driver ­– Growth In Prevalence Of Cancer And Macular Degeneration Diseases

For instance, in August 2022, according to this systematic review and meta-analysis published by the National Library of Medicine, a US-based medical library, age-related macular degeneration will affect 8–7% of the global population, with the illness affecting 196 million individuals in 2020 and rising to 288 million by 2040. Anti-vascular endothelial growth factor (anti-VEGF) agents halt the progression of the disease and improve vision. A vascular endothelial growth factor (VEGF) inhibitor slows and restricts tumor growth during cancers. Hence, the rising prevalence of cancer along with macular degeneration disease aids in the growth of the vascular endothelial growth factor (VEGF) inhibitor market over the forecast period.

Request for A Sample Of The Global Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3437&type=smp

Key Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Trend – Developing New Products

Key players operating in the industry are undergoing various collaborations and partnerships to expand their product portfolio by developing new products. For instance, in May 2020, AbbVie, a US-based biopharmaceutical company acquired Allergan, Inc., a US-based pharmaceutical company focused on eye care. This acquisition establishes a biopharma firm with leadership roles in vital therapeutic areas such as hematologic oncology, immunology, Allergan Aesthetics, and neuroscience. Furthermore, in January 2020, Exonate, a biotechnology company, collaborated with Janssen Pharmaceuticals, a subsidiary of Johnson & Johnson for the development of a new eye drop for the treatment of retinal vascular diseases. Exonerate developed small molecules that inhibit the production of pro-angiogenic vascular endothelial growth factor (VEGF) through the selective inhibition of serine/threonine-protein kinase (SRPK1)-mediated VEGF splicing.

Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Segment

1) By Drugs Type: Avastin, Tecentriq, Cometriq, Eylea, Other Drug Types

2) By Route Of Administration: Oral, Intravenous

3) By Application: Oncology, Ophthalmology, Other Applications

Vascular Endothelial Growth Factor (VEGF) Inhibitor Market Major Players and Strategies

Major players in the vascular endothelial growth factor (VEGF) inhibitor market are Pfizer, Amgen, Roche, Xbrane Biopharma AB, Genentech Inc., AstraZeneca PLC., Bayer AG, Eli Lilly and Company and Allergan PLC.

In May 2020, AbbVie Inc., a US-based biopharmaceutical company, acquired Allergan plc for an amount of $63 billion. This acquisition is expected to give AbbVie Inc. an enhanced long-term growth potential along with a growing dividend and investment in innovation in each of Allergan plc’s therapeutic categories. Allergan plc is an Ireland-based pharmaceutical company engaged in the manufacturing of drugs and medical devices in the field of eye care, medical aesthetics, gastroenterology, and the central nervous system.

The Vascular Endothelial Growth Factor (VEGF) Inhibitor Global Market Report 2023 covers regional data on vascular endothelial growth factor (VEGF) inhibitor market size, vascular endothelial growth factor (VEGF) inhibitor market trends and drivers, opportunities, strategies, and vascular endothelial growth factor (VEGF) inhibitor market competitor analysis. The countries covered in the vascular endothelial growth factor (VEGF) inhibitor market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, the UK, and the USA, and the major seven regions are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, the Middle East, and Africa.

A VEGF inhibitor is an inhibitor that prevents planned cell death by acting as an anti-apoptotic factor for hematopoietic cells. VEGF increases vascular permeability, which may make it easier for tumours to spread via the bloodstream and receive more oxygen and nutrients.

View More Reports Related To The Vascular Endothelial Growth Factor (VEGF) Inhibitor Market –

Vascular Grafts Global Market Report 2023

Vascular Stent Global Market Report 2023

Peripheral Vascular Devices And Equipment Global Market Report 2023

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]

Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: